Efficacy and safety of umbilical cord mesenchymal stem cells for the treatment of patients with COVID-19.

Fengtao Wei Dexiao Kong Tao Li Ai Li Yi Tan Jinfeng Fang Xianghua Zhuang Chao Lai Weihua Xu Hong Dong Chengen Ma Ke Hong Yuqin Cui Shengbin Tang Fenggang Yu Chengyun Zheng

Published in: Clinics (Sao Paulo, Brazil) (2021)

Intravenous infusion of MSCs in patients with COVID-19 was effective and well tolerated. Further studies involving a large cohort or randomized controlled trials are warranted.

Keyphrases

umbilical cord
mesenchymal stem cells
randomized controlled trial
bone marrow
cell therapy
low dose
high dose
systematic review
case control
combination therapy
meta analyses